Managing Complex Patients - US | Kuritzkes

Managing Complex HIV Patients 2020- US Edition

Managing Complex Patients - US | Kozal

Managing Complex HIV Patients 2020- US Edition

Host-microbiome interactions at the oral mucosal barrier - Niki Moutsopoulos, DDS, PhD

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2019

Regulation of intestinal viral infections by the microbiota - Megan Baldridge, MD, PhD

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2019

Glycomic Determinants of Gut Microbial Dysbiosis and Translocation During Suppressed HIV Infection - Leila Giron

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2019

Host Genetic Determinants of the Vaginal Microbiome and Bacterial Vaginosis in Kenyan Women - Supriya Mehta

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2019

ELEVATED FECAL INFLAMMATORY BIOMARKERS IN HIV-/+ MSM ASSOCIATE WITH GUT MICROBIOTA - Jennifer Schneider

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2019

Metaproteomics to understand mucosal inflammation associated with HIV acquisition risk in young African women - Lindi Masson

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2019

Update on live biotherapeutic trials to prevent vaginal dysbiosis and HIV - Craig Cohen, MD, MPH

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2019

Oral Fecal Microbiota Transplantation Increases Gut Microbiome Diversity and Alters the Microbiome Distribution in People with HIV - Netanya Utay, MD

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2019

The relationship between the gut microbiome, inflammation and metabolic disease in HIV infected and high risk populations - Catherine Lozupone

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2019

Endotoxemia, inflammation and HIV: Revisiting an old concept - Jean-Pierre Routy, MD

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2019

Microbial therapeutics and opportunities in HIV - Ma Somsouk

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2019

Development of a live biotherapeutic product: Opportunities and challenges - Scott Plevy, MD

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2019

Sexual health clinic-based delivery model - Rena Janamnuaysook, MBA

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Pharmacokinetics of tenofovir alafenamide 25 mg with PK boosters during pregnancy and postpartum - Kristina Brooks, PharmD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Infectious disease action plan for the global accelerator for paediatric formulations (GAP-f) - Paul Domanico, PhD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Pharmacokinetics of atazanavir boosted with cobicistat during pregnancy and postpartum - Jeremiah Momper

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Infant exposure to dolutegravir through placental and breastmilk transfer: A population PK analysis of DolPHIN-1 - Laura Dickinson

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Low isoniazid concentrations in pregnant and postpartum women treated for tuberculosis irrespective of efavirenz-based ART co-treatment - Marije Van Schalkwyk, MD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Tenofovir-diphosphate in PBMC following increasing TAF vs. TDF dosing under directly observed therapy - Jenna Yager

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

An exploration of adherence measures to detect recent changes in Truvada® dosing patterns - Daijha Anderson

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Physiologically based pharmacokinetic modelling to determine pharmacokinetic alterations driving ritonavir exposure changes in aging people living with HIV - Felix Stader

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Physiologically-based pharmacokinetic modeling of rilpivirine during pregnancy - Mary Gockenbach

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019